Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.
Dr. Michor delivered her award lecture titled "Biology and Dynamics of Cancer Evolution" at the Annual Meeting 2016 in New Orleans, Louisiana. The award lecture was held Sunday, April 17, 2016, at the Morial Convention Center. Read more Here
Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig, has given Harvard Medical School $90 million to spur innovative scientific inquiry and discovery. This gift reflects a portion of a $540 million gift divided equally among Ludwig Centers at six academic institutions throughout the U.S. According to the Ludwig announcement, this new financial support is among the largest private gifts for cancer research.